Report Detail
Global Age-related Macular Degeneration Market Insights, Forecast to 2025
- RnM3184109 |
- 25 March, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Age-related Macular Degeneration market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Age-related Macular Degeneration market based on company, product type, end user and key regions.
This report studies the global market size of Age-related Macular Degeneration in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Age-related Macular Degeneration in these regions.
This research report categorizes the global Age-related Macular Degeneration market by top players/brands, region, type and end user. This report also studies the global Age-related Macular Degeneration market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Market size by Product
Wet AMD
Dry AMD
Market size by End User
Drugstore
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Age-related Macular Degeneration market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Age-related Macular Degeneration market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Age-related Macular Degeneration companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Age-related Macular Degeneration submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Age-related Macular Degeneration are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Age-related Macular Degeneration market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Age-related Macular Degeneration Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Age-related Macular Degeneration Market Size Growth Rate by Product
- 1.4.2 Wet AMD
- 1.4.3 Dry AMD
- 1.5 Market by End User
- 1.5.1 Global Age-related Macular Degeneration Market Size Growth Rate by End User
- 1.5.2 Drugstore
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Age-related Macular Degeneration Market Size
- 2.1.1 Global Age-related Macular Degeneration Revenue 2014-2025
- 2.1.2 Global Age-related Macular Degeneration Sales 2014-2025
- 2.2 Age-related Macular Degeneration Growth Rate by Regions
- 2.2.1 Global Age-related Macular Degeneration Sales by Regions
- 2.2.2 Global Age-related Macular Degeneration Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Age-related Macular Degeneration Sales by Manufacturers
- 3.1.1 Age-related Macular Degeneration Sales by Manufacturers
- 3.1.2 Age-related Macular Degeneration Sales Market Share by Manufacturers
- 3.1.3 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
- 3.2 Age-related Macular Degeneration Revenue by Manufacturers
- 3.2.1 Age-related Macular Degeneration Revenue by Manufacturers (2014-2019)
- 3.2.2 Age-related Macular Degeneration Revenue Share by Manufacturers (2014-2019)
- 3.3 Age-related Macular Degeneration Price by Manufacturers
- 3.4 Age-related Macular Degeneration Manufacturing Base Distribution, Product Types
- 3.4.1 Age-related Macular Degeneration Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Age-related Macular Degeneration Product Type
- 3.4.3 Date of International Manufacturers Enter into Age-related Macular Degeneration Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Age-related Macular Degeneration Sales by Product
- 4.2 Global Age-related Macular Degeneration Revenue by Product
- 4.3 Age-related Macular Degeneration Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Age-related Macular Degeneration Breakdown Data by End User
6 North America
- 6.1 North America Age-related Macular Degeneration by Countries
- 6.1.1 North America Age-related Macular Degeneration Sales by Countries
- 6.1.2 North America Age-related Macular Degeneration Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Age-related Macular Degeneration by Product
- 6.3 North America Age-related Macular Degeneration by End User
7 Europe
- 7.1 Europe Age-related Macular Degeneration by Countries
- 7.1.1 Europe Age-related Macular Degeneration Sales by Countries
- 7.1.2 Europe Age-related Macular Degeneration Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Age-related Macular Degeneration by Product
- 7.3 Europe Age-related Macular Degeneration by End User
8 Asia Pacific
- 8.1 Asia Pacific Age-related Macular Degeneration by Countries
- 8.1.1 Asia Pacific Age-related Macular Degeneration Sales by Countries
- 8.1.2 Asia Pacific Age-related Macular Degeneration Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Age-related Macular Degeneration by Product
- 8.3 Asia Pacific Age-related Macular Degeneration by End User
9 Central & South America
- 9.1 Central & South America Age-related Macular Degeneration by Countries
- 9.1.1 Central & South America Age-related Macular Degeneration Sales by Countries
- 9.1.2 Central & South America Age-related Macular Degeneration Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Age-related Macular Degeneration by Product
- 9.3 Central & South America Age-related Macular Degeneration by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Age-related Macular Degeneration by Countries
- 10.1.1 Middle East and Africa Age-related Macular Degeneration Sales by Countries
- 10.1.2 Middle East and Africa Age-related Macular Degeneration Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Age-related Macular Degeneration by Product
- 10.3 Middle East and Africa Age-related Macular Degeneration by End User
11 Company Profiles
- 11.1 Bayer HealthCare
- 11.1.1 Bayer HealthCare Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer HealthCare Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer HealthCare Age-related Macular Degeneration Products Offered
- 11.1.5 Bayer HealthCare Recent Development
- 11.2 F. Hoffmann-La Roche
- 11.2.1 F. Hoffmann-La Roche Company Details
- 11.2.2 Company Business Overview
- 11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 F. Hoffmann-La Roche Age-related Macular Degeneration Products Offered
- 11.2.5 F. Hoffmann-La Roche Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis Age-related Macular Degeneration Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Regeneron Pharmaceuticals
- 11.4.1 Regeneron Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Regeneron Pharmaceuticals Age-related Macular Degeneration Products Offered
- 11.4.5 Regeneron Pharmaceuticals Recent Development
- 11.5 Alcon
- 11.5.1 Alcon Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Alcon Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Alcon Age-related Macular Degeneration Products Offered
- 11.5.5 Alcon Recent Development
- 11.6 Allergan
- 11.6.1 Allergan Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Allergan Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Allergan Age-related Macular Degeneration Products Offered
- 11.6.5 Allergan Recent Development
- 11.7 Avalanche
- 11.7.1 Avalanche Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Avalanche Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Avalanche Age-related Macular Degeneration Products Offered
- 11.7.5 Avalanche Recent Development
- 11.8 Bausch+Lomb
- 11.8.1 Bausch+Lomb Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bausch+Lomb Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bausch+Lomb Age-related Macular Degeneration Products Offered
- 11.8.5 Bausch+Lomb Recent Development
- 11.9 Gilead Sciences
- 11.9.1 Gilead Sciences Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Gilead Sciences Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Gilead Sciences Age-related Macular Degeneration Products Offered
- 11.9.5 Gilead Sciences Recent Development
- 11.10 Iconic Therapeutics
- 11.10.1 Iconic Therapeutics Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Iconic Therapeutics Age-related Macular Degeneration Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Iconic Therapeutics Age-related Macular Degeneration Products Offered
- 11.10.5 Iconic Therapeutics Recent Development
- 11.11 Neurotech Pharmaceuticals
- 11.12 Ohr Pharmaceutical
12 Future Forecast
- 12.1 Age-related Macular Degeneration Market Forecast by Regions
- 12.1.1 Global Age-related Macular Degeneration Sales Forecast by Regions 2019-2025
- 12.1.2 Global Age-related Macular Degeneration Revenue Forecast by Regions 2019-2025
- 12.2 Age-related Macular Degeneration Market Forecast by Product
- 12.2.1 Global Age-related Macular Degeneration Sales Forecast by Product 2019-2025
- 12.2.2 Global Age-related Macular Degeneration Revenue Forecast by Product 2019-2025
- 12.3 Age-related Macular Degeneration Market Forecast by End User
- 12.4 North America Age-related Macular Degeneration Forecast
- 12.5 Europe Age-related Macular Degeneration Forecast
- 12.6 Asia Pacific Age-related Macular Degeneration Forecast
- 12.7 Central & South America Age-related Macular Degeneration Forecast
- 12.8 Middle East and Africa Age-related Macular Degeneration Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Age-related Macular Degeneration Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Age-related Macular Degeneration . Industry analysis & Market Report on Age-related Macular Degeneration is a syndicated market report, published as Global Age-related Macular Degeneration Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Age-related Macular Degeneration market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
